4.3 Article

Cancer prevalence in Italy: an analysis of geographic variability

Related references

Note: Only part of the references are listed.
Article Oncology

Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors

William R. Carpenter et al.

CANCER CAUSES & CONTROL (2011)

Article Oncology

Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers

Maryska L. G. Janssen-Heijnen et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

Cancer prevalence in the United Kingdom: estimates for 2008

J. Maddams et al.

BRITISH JOURNAL OF CANCER (2009)

Article Oncology

The cure of cancer: A European perspective

Silvia Francisci et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Oncology

Practical Application of a Calculator for Conditional Survival in Colon Cancer

George J. Chang et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Health Care Sciences & Services

Overview of Methods to Estimate the Medical Costs of Cancer

William E. Barlow

MEDICAL CARE (2009)

Article Oncology

Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012

Marc Colonna et al.

EUROPEAN JOURNAL OF CANCER (2008)

Article Mathematical & Computational Biology

Estimating and modeling the cure fraction in population-based cancer survival analysis

Paul C. Lambert et al.

BIOSTATISTICS (2007)

Article Oncology

Standard cancer patient population for age standardising survival ratios

I Corazziari et al.

EUROPEAN JOURNAL OF CANCER (2004)

Article Oncology

Cancer prevalence in European registry areas

A Micheli et al.

ANNALS OF ONCOLOGY (2002)

Article Oncology

Measuring cancer prevalence in europe: the EUROPREVAL project

R Capocaccia et al.

ANNALS OF ONCOLOGY (2002)

Article Oncology

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population

P Pisani et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Article Public, Environmental & Occupational Health

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program

RM Merrill et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2000)